Target intelligence / Profile preview

Propionyl-CoA carboxylase (PCC)

Target
PCC
Molecular classification
Enzyme, Ligase (EC 6.4.1.3)
01

Overview

Propionyl-CoA carboxylase is a biotin-dependent mitochondrial enzyme that catalyzes the ATP-dependent carboxylation of propionyl-CoA to form D-methylmalonyl-CoA, a key step in the breakdown of certain amino acids (valine, isoleucine, methionine, threonine), odd-chain fatty acids, and cholesterol[1][5]. The enzyme functions as an alpha(6)beta(6) dodecamer composed of six alpha and six beta subunits encoded by the nuclear genes PCCA and PCCB respectively[2][6]. The reaction it catalyzes provides intermediates for gluconeogenesis via succinyl-CoA entry into the Krebs cycle[1]. Deficiency or dysfunction due to genetic mutations causes propionic acidemia—a severe inherited metabolic disorder characterized by accumulation of toxic metabolites leading to neurological damage and potentially fatal neonatal crises if untreated[5][2]. No approved drugs directly target this enzyme; current therapies focus on dietary management and supportive care for affected individuals.

Other names
Propionyl coenzyme A carboxylasePCCasePropanoyl-CoA:carbon dioxide ligasePCCA (alpha subunit gene)PCCB (beta subunit gene)
02

Biological functions

Fatty acid metabolismAmino acid catabolism (valine, isoleucine, methionine, threonine)Gluconeogenesis precursor generation
03

Disease associations

Inborn error of metabolism (propionic acidemia)
04

Safety considerations

Deficiency leads to toxic metabolite accumulation and severe neonatal metabolic crisis
05

Biomarkers

Mutations in PCCA or PCCB genes for propionic acidemia diagnosis

Beyond the preview

Go deeper on Propionyl-CoA carboxylase (PCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Propionyl-CoA carboxylase (PCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call